{
    "clinical_study": {
        "@rank": "41916", 
        "arm_group": {
            "arm_group_label": "Ganfort\u00ae", 
            "description": "Patients who receive treatment with bimatoprost/timolol (Ganfort\u00ae) for open-angle glaucoma or ocular hypertension as per local standard of care in clinical practice."
        }, 
        "brief_summary": {
            "textblock": "This study is a Post-Marketing Surveillance study to evaluate the safety and efficacy of\n      bimatoprost/timolol (Ganfort\u00ae) Ophthalmic  Solution to treat open-angle glaucoma or ocular\n      hypertension in Korea."
        }, 
        "brief_title": "Safety and Efficacy of Bimatoprost/Timolol (Ganfort\u00ae) Ophthalmic Solution in Korea", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": [
            "Glaucoma, Open-Angle", 
            "Ocular Hypertension"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Glaucoma", 
                "Glaucoma, Open-Angle", 
                "Hypertension", 
                "Ocular Hypertension"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients treated with Ganfort\u00ae for open-angle glaucoma or ocular hypertension in\n             clinical practice.\n\n        Exclusion Criteria:\n\n          -  None."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients treated with Ganfort\u00ae for open-angle glaucoma or ocular hypertension in clinical\n        practice."
            }
        }, 
        "enrollment": {
            "#text": "756", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01976624", 
            "org_study_id": "192024-087"
        }, 
        "intervention": {
            "arm_group_label": "Ganfort\u00ae", 
            "description": "Bimatoprost/timolol (Ganfort\u00ae) treatment for open-angle glaucoma or ocular hypertension as per local standard of care in clinical practice.", 
            "intervention_name": "bimatoprost/timolol", 
            "intervention_type": "Drug", 
            "other_name": "Ganfort\u00ae"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Timolol", 
                "Bimatoprost"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "lastchanged_date": "April 24, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of"
                }
            }
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_groups": "1", 
        "overall_official": {
            "affiliation": "Allergan", 
            "last_name": "Medical Director", 
            "role": "Study Director"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "primary_outcome": [
            {
                "measure": "Investigator Assessment of Patient's Overall Improvement Based on Intraocular Pressure (IOP)", 
                "safety_issue": "No", 
                "time_frame": "Week 4"
            }, 
            {
                "measure": "Number of Participants with Adverse Events and Adverse Drug Reactions", 
                "safety_issue": "No", 
                "time_frame": "6 Years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01976624"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "measure": "Change from Baseline in IOP", 
            "safety_issue": "No", 
            "time_frame": "Baseline, Week 4"
        }, 
        "source": "Allergan", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Allergan", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "August 2009", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}